Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Investigation

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI19585PMID 14755342PMCID PMC324541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules

  2003cited by this paper
• HLA Class II-Restricted CD4 T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination

  2003cited by this paper
• HLA Class II-Restricted CD4+ T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination 1

  2003cited by this paper
• Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop.

  2003cited by this paper
• Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes

  2003cited by this paper
• Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

  2003cited by this paper
• Diabetes Antibody Standardization Program: first assay proficiency evaluation.

  2003cited by this paper
• Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

  2002cited by this paper
• Cutting Edge: Anti-Inflammatory Properties of Low Levels of IFN-γ1

  2002cited by this paper
• The enemy within: keeping self-reactive T cells at bay in the periphery

  2002cited by this paper
• Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.

  2002cited by this paper
• Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes

  2002cited by this paper
• Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

  2002cited by this paper
• Regulatory Role of T Cells Producing both Interferon γ and Interleukin 10 in Persistent Infection

  2001cited by this paper
• Suppressor T cells – they’re back and critical for regulation of autoimmunity!

  2001cited by this paper
• A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes

  2001cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

  2001cited by this paper
• Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.

  2001cited by this paper
• Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation1

  2001cited by this paper
• Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

  2001cited by this paper
• Update on Major Trials for the Prevention of Type I Diabetes Mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)

  2001cited by this paper
• T-Cell markers in Type I diabetes: progress, prospects and realistic expectations

  2000cited by this paper
• Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.

  1999influential reference
• Streamlined procedure for the production of normal and altered versions of recombinant human proinsulin.

  1999cited by this paper
• Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes.

  1999cited by this paper
• Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

  1999cited by this paper
• Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.

  1999influential reference
• T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes

  1999cited by this paper
• SYFPEITHI: database for MHC ligands and peptide motifs

  1999cited by this paper
• T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin.

  1998cited by this paper
• Enhanced T cell proliferation and increased responder frequency following delivery of antigen to the antigen-presenting cell; B cell dependency and use in detection of autoreactive T cells.

  1998cited by this paper
• Expression, purification and characterization of recombinant human proinsulin

  1997influential reference
• Susceptibility to type I diabetes: HLA-DQ and DR revisited.

  1996cited by this paper
• T-Cell Responses to Autoantigens in IDDM: The Search for the Holy Grail

  1996cited by this paper
• T helper cell subsets in insulin-dependent diabetes.

  1995cited by this paper
• Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

  1995cited by this paper
• Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

  1989cited by this paper
• The use of relative operating characteristic (ROC) curves in test performance evaluation.

  1986cited by this paper
• Primer on certain elements of medical decision making.

  1975cited by this paper

• Peptide-Based Therapeutics in Autoimmune Diseases: Restoring Immune Balance Through Precision

  2026cites this paper
• GM-CSF+ Th: a central player in autoimmunity

  2025cites this paper
• Pivotal epitopes for islet antigen-specific CD8+ T cell detection improve classification of suspected type 1 diabetes with the HLA-A*0201 allele

  2025cites this paper
• Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians

  2025cites this paper
• Proximity extension assay inflammatory profiling cannot distinguish the presence of residual C-peptide in patients with long-standing type 1 diabetes

  2025cites this paper
• The Pathogenesis of Type 1 Diabetes.

  2024cites this paper
• Biological function of type 1 regulatory cells and their role in type 1 diabetes

  2024cites this paper
• Microparticles incorporating dual apoptotic factors to inhibit anti-inflammatory effects in macrophages.

  2024cites this paper
• Cracking the type 1 diabetes code: Genes, microbes, immunity, and the early life environment

  2024cites this paper
• Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes

  2024cites this paper
• First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

  2024cites this paper
• The initiation of a migraine associated with a specific gene responsible for regulating immune Function: Hypothesis

  2024cites this paper
• Single-cell analysis reveals islet autoantigen’s immune activation in type 1 diabetes patients

  2024cites this paper
• Physiological and pathogenic T cell autoreactivity converge in type 1 diabetes

  2024cites this paper
• The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus

  2024influential citation
• Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6.

  2024cites this paper
• Early-life exposures to specific commensal microbes prevent type 1 diabetes

  2024cites this paper
• Review on Monoclonal Antibodies (mAbs) as a Therapeutic Approach for Type 1 Diabetes.

  2023cites this paper
• The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes

  2023cites this paper
• A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice

  2023cites this paper
• Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease

  2023cites this paper
• The PTGS2/COX2-PGE2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus

  2023cites this paper
• Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans

  2023cites this paper
• T Cell Response to SARS-CoV-2 Coinfection and Comorbidities

  2023cites this paper
• Human immune phenotyping reveals accelerated aging in type 1 diabetes

  2023cites this paper
• Human immune phenotyping reveals accelerated aging in type 1 diabetes

  2023cites this paper
• Monitoring immunomodulation strategies in type 1 diabetes

  2023cites this paper
• HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients

  2023cites this paper
• Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials

  2023cites this paper
• Activation pathways that drive CD4+ T cells to break tolerance in autoimmune diseases *

  2022cites this paper
• Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes

  2022cites this paper
• Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients

  2022cites this paper
• Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease

  2022cites this paper
• Posttranslational modifications in diabetes: Mechanisms and functions

  2022cites this paper
• From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes

  2022cites this paper
• Human CD4+CD25+CD226- Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4+CD25+CD127lo/- Tregs for Adoptive Cell Therapy

  2022cites this paper
• Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse.

  2022cites this paper
• Evaluating T cell responses prior to the onset of type 1 diabetes

  2022cites this paper
• Prosopis strombulifera aqueous extract reduces T cell response and ameliorates type I diabetes in NOD mice

  2022cites this paper
• Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes

  2022cites this paper
• Type 1 regulatory T cell-mediated tolerance in health and disease

  2022cites this paper
• What Is a Honeymoon in Type 1, Can It Go into Remission?

  2022cites this paper
• Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases

  2022influential citation
• Insulin’s other life: an autoantigen in type 1 diabetes

  2021cites this paper
• Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes

  2021cites this paper
• T-cell responses to hybrid insulin peptides prior to type 1 diabetes development

  2021cites this paper
• Proinsulin-Reactive CD4 T Cells in the Islets of Type 1 Diabetes Organ Donors

  2021cites this paper
• Evolving Antibody Therapies for the Treatment of Type 1 Diabetes

  2021cites this paper
• Peripheral autoreactive CD8 T‐cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes

  2021influential citation
• Negative Regulation of FOXP3 Expression by c-Rel O-GlcNAcylation.

  2021cites this paper
• Helminth protection against type-1 diabetes: an insight into immunomodulatory effect of helminth-induced infection

  2021cites this paper
• Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes

  2021cites this paper
• Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy

  2021cites this paper
• Effects of in vitro vitamin D treatment on function of T cells and autophagy mechanisms in high-fat diet-induced obese mice

  2021cites this paper
• The β Cell in Diabetes: Integrating Biomarkers with Functional Measures.

  2021cites this paper
• Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects

  2021cites this paper
• Identification of an Autoantibody Against ErbB-3-Binding Protein-1 in the Sera of Patients With Chronic Hepatitis B Virus Infection

  2021cites this paper
• Proinsulin‐specific T‐cell responses correlate with estimated c‐peptide and predict partial remission duration in type 1 diabetes

  2021cites this paper
• Noncontiguous T cell epitopes in autoimmune diabetes: From mice to men and back again

  2021cites this paper
• Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot’s Print

  2021cites this paper
• Potential Therapeutic Application of Regulatory T Cells in Diabetes Mellitus Type 1

  2021cites this paper
• The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes

  2021cites this paper
• Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes

  2021cites this paper
• Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

  2021cites this paper
• Autoimmune (Type 1) Diabetes

  2020cites this paper
• Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes

  2020cites this paper
• Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects via Adult Progenitor Cell Co-Culture

  2020cites this paper
• Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

  2020cites this paper
• Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re‐emerging phenotype is associated with graft function

  2020cites this paper
• Autoimmune facet of type 1 diabetes

  2020cites this paper
• Distinct Phenotypes of Islet Antigen-specific CD4+ T Cells among the Three Subtypes of Type 1 Diabetes.

  2020cites this paper
• Assessing effector T cells in type 1 diabetes.

  2020cites this paper
• Diagnostic value of combined islet antigen‐reactive T cells and autoantibodies assays for type 1 diabetes mellitus

  2020cites this paper
• Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?

  2020cites this paper
• Animal Models of Organ-Specific Autoimmune Disease

  2020cites this paper
• Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes

  2020cites this paper
• Breakdown of T-cell ignorance: The tolerance failure responsible for mainstream autoimmune diseases?

  2020influential citation
• Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes

  2020cites this paper
• Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes–Associated HLA Class II Molecules

  2020cites this paper
• Neutrophil Extracellular Trap Induced Dendritic Cell Activation Leads to Th1 Polarization in Type 1 Diabetes

  2020cites this paper
• Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease

  2019cites this paper
• Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study

  2019cites this paper
• Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes

  2019cites this paper
• Type 1 diabetes impairs the mobilisation of highly-differentiated CD8+T cells during a single bout of acute exercise.

  2019cites this paper
• Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes

  2019cites this paper
• Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer–mediated autoimmune diabetes

  2019cites this paper
• Reversal of New Onset Type 1 Diabetes by Oral Salmonella-Based Combination Therapy and Mediated by Regulatory T-Cells in NOD Mice

  2019cites this paper
• Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine.

  2019cites this paper
• The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review

  2019cites this paper
• The role of ERAP1 in autoinflammation and autoimmunity.

  2019cites this paper
• Adenoviral gene transfer of a single‐chain IL‐23 induces psoriatic arthritis–like symptoms in NOD mice

  2019cites this paper
• A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes

  2019influential citation
• Sex Differences in Autoimmune Type-1 Diabetes

  2019cites this paper
• Harnessing CXCL12 signaling to protect and preserve functional &bgr;‐cell mass and for cell replacement in type 1 diabetes

  2019influential citation
• Replacing murine insulin 1 with human insulin protects NOD mice from diabetes

  2019cites this paper
• Monocytes Prime Autoreactive T cells After Myocardial Infarction.

  2019cites this paper
• Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

  2019cites this paper
• Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases.

  2019cites this paper
• Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry

  2019cites this paper
• Genetics of Type 1 Diabetes Comes of Age

  2019cites this paper